Related Experiment Video
Updated: Oct 31, 2025

07:15
Orthotopic Hind Limb Transplantation in the Mouse
Published on: February 12, 2016
12.0K
Generation of vascular chimerism within donor organs
Shahar Cohen1, Shirly Partouche2,3, Michael Gurevich4
1Laboratory for Organ Bioengineering, Rabin Medical Center, Petah Tikva, Israel. shaharco@gmail.com.
Scientific Reports
|June 29, 2021
Summary
Replacing donor endothelial cells in decellularized organs offers a feasible path to engineering transplantable organs. This vascular chimerism approach could overcome immune barriers in xenotransplantation and reduce rejection in allogeneic grafts.
Area of Science:
- Regenerative Medicine
- Tissue Engineering
- Transplantation Immunology
Background:
- Whole organ decellularization aims to create non-immunogenic grafts from different donors.
- Recellularizing decellularized organs with patient-specific cells in a controlled manner is a significant challenge.
- Replacing only donor endothelial cells presents a more feasible approach to organ engineering.
Purpose of the Study:
- To investigate the feasibility of vascular decellularization and recellularization for organ transplantation.
- To explore the potential of endothelial progenitor cells (EPCs) in repopulating decellularized vascular networks.
- To assess the possibility of creating vascular chimerism to overcome immunological barriers in transplantation.
Main Methods:
- Vascular decellularization of rat and porcine organs (kidneys, liver, lungs, heart, aorta, limbs, pancreas) using machine perfusion (ex vivo and in situ).
- Repopulation of de-endothelialized vascular scaffolds with human placenta-derived endothelial progenitor cells (EPCs).
- In vitro and ex vivo recellularization of aorta, kidneys, lungs, and hind limbs.
Main Results:
- Successful vascular decellularization was achieved in multiple organs using machine perfusion.
- Human EPCs effectively repopulated the luminal surface of de-endothelialized vascular structures.
- Demonstrated the feasibility of generating vascular chimerism in decellularized organs.
Conclusions:
- Replacing donor endothelial cells alone is a technically feasible strategy for organ engineering.
- Artificially generated vascular chimerism shows promise for overcoming immunological barriers in xenotransplantation.
- This approach may reduce the immunological burden associated with allogeneic grafts, advancing organ transplantation efforts.
Related Concept Videos
Tissue Transplantation
667
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
667
Bone Marrow Sampling and Transplants
599
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
599

